micro glp-1 Microdosing 1 is PlexusDxs entry FITISH GLP-1 MICRODOSING PROGRAM
Description
Rybelsus mimics natural GLP-1 hormone, enhancing glucose-dependent insulin secretion, suppressing glucagon, and slowing gastric emptying to improve glycaemic control

Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans
Specifically, continuous infusion (0.944.8 nM) or intragastric dosing (0.050.1 mg/mL for 5 days) increased insulin and decreased glucose

SGLT2is exhibits multiple beneficial effects beyond glycemic control, including reductions in body weight, blood pressure, and cardiovascular events 5
